We use cookies for a better user experience. Read our Privacy Policy

I Agree

Synthetic Biology Market

Synthetic Biology Market (Product Type: Core Products, Enabling Products, DNA Synthesis, and Oligonucleotide Synthesis) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Synthetic Biology Market Outlook 2031

  • The global synthetic biology market was valued at US$ 10.7 Bn in 2021
  • The global market is projected to advance at a CAGR of 21.3% from 2022 to 2031
  • The global synthetic biology market is anticipated to reach more than US$ 74.7 Bn by the end of 2031

Analysts’ Viewpoint on Synthetic Biology Market Scenario

The synthetic biology market is growing at a rapid pace owing to the increase in demand for renewable fuel and bio-based chemicals; and inexpensive drugs and vaccines, which utilize synthetic biology techniques and products. Additionally, participation of various organizations, such as BioBricks, DIYbio, and SynBERC, in the development of synthetic biology is expected to augment the global synthetic biology market during the forecast period. Rise in advancements in synthetic biology and increase in demand for genetically modified crops due to surging population are also driving the global synthetic biology market. Companies operating in the market are focusing on innovation in the field of synthetic biology, such as cell free synthetic biology, to enhance their revenue streams.

Synthetic Biology Market

Synthetic Biology Market Introduction

Synthetic biology is a branch of science that deals with the re-engineering of organisms for useful purpose by transforming them into new possibilities. Synthetic biologists and key players across the world are harnessing the power of nature to solve problems in medicine, manufacturing, and agriculture. Synthetic biology projects often aim to redesign organisms to make a substance, such as a drug or fuel, or acquire a new ability such as sensing something in the environment. Microorganisms used for bioremediation, rice modified to produce beta-carotene, and yeast modified to produce rose oil are some examples of synthetic biology.

Molecular genetics has become an integral part of biomedical science and clinical practice, having major implications in deciphering the pathogenesis and progression of disease, identifying diagnostic markers & prognosis, and designing better targeted treatments. Synthetic biology in medicine plays an important role in the health and wellness market. Synthetic biology devices not only help advance the understanding of disease mechanisms, but also provide new diagnostic tools. Synthetic biology-based methods enable the development of new strategies for the treatment of cancer, immune disorders, metabolic disorders, infectious diseases, and manufacture of inexpensive pharmaceuticals.

Request a sample to get extensive insights into the Synthetic Biology Market

Rise in Demand for Improved Drugs and Vaccines to Drive Global Synthetic Biology Market

Synthetic biology is one of the solutions to reduce the risk of antibiotic-resistant microorganisms, which is a significant threat to drug development organizations. Manufacturers are applying synthetic biology to drug and vaccine development, as it is a process in which man-made biological materials are produced using biological devices and systems. Synthetic biology is a process widely accepted by companies for the production of innovative and personalized drugs (drugs and vaccines). In 2014, the Massachusetts Institute of Technology (MIT) partnered with Pfizer to develop personalized and innovative drugs. Rise in prevalence of infectious diseases is driving the global synthetic biology market share. Infectious diseases such as H1N1, H1N5, and dengue fever are rampant among the population, and individualized and innovative treatments (drugs or vaccines) are needed to overcome them. Therefore, pharmaceutical companies have changed/adopted synthetic biology processes to recognize and improve the treatment of a particular disease/disorder. The global synthetic biology market trends indicate significant growth related to treatment enhancement.

Advancement in Molecular Biology to Boost Demand for Synthetic Biology

Synthetic biology uses gene synthesis and DNA sequencing at a basic level to perform advanced experiments. Rapid progress has been made in the field of molecular biotechnology such as FISH, PCR, and aCGH. Advent of these innovative technologies enables experts to detect genetic anomalies and hidden chromosomal aberrations at an early stage of a disease. The FISH technique detects changes in chromosome number and structure. PCR is a revolutionary sequencing method that can generate millions of DNA in a short time. The results obtained from this technique help doctors to decide what type of treatment is needed for a patient and monitor him or her during treatment selection. Array CGH is another molecular biology technique, which is widely used for clinical research in constitutional cytogenetics, rare diseases, cancer, and reproductive health. aCGH provides high-resolution, genome-wide analysis for the detection of chromosome-wide aneuploidies, microsatellite deletions, and single exon-resolution duplication and replication neutral events such as loss of heterozygosity (LoH) and uniparental disomy (UPD). Rapid advancements in molecular biology enable researchers to find an effective result within a short time. Thus, advancement in molecular biology is driving the global synthetic biology market size.

Request a custom report on Synthetic Biology Market

Superior Benefits and Satisfaction Fueling Core Products Segment

In terms of product type, the global synthetic biology market has been bifurcated into core products and enabling products. The core products segment has been classified into synthetic DNA, synthetic genes, synthetic cells, synthetic clones XNA & chassis organisms, and others. The synthetic DNA sub-segment dominated the core products segment in 2021. Core products include a range of products that provide superior consumer benefits and satisfaction. These are tools designed primarily for high level synthesis products. Synthetic DNA can bring out the functions of cells by artificially building them into existing DNA. These DNAs are injected directly into the cell nucleus to build a synthetic organism with the desired functionality. Synthetic genes are generated artificially for the development of economic genes that satisfy specific needs of consumers. These genes are produced in laboratories or clinics using artificial gene synthesis to modify the sequences of genes. Advancement in synthetic biology and introduction of advanced technologies in the field of genetic, biology, engineering and computer sciences are augmenting the synthetic DNA sub-segment.

Usage in Modification of Genetic Foods, Gene Cloning, and Gene Therapy Propelling Genome Engineering Segment

Based on technology, the global synthetic biology market has been classified into genome engineering, DNA sequencing, bioinformatics, biological components & integrated systems, microfluides, nanotechnology, and others. The genome engineering segment held major share of the global market in 2021. Genome engineering can be used to modify genetic foods, gene cloning, and gene therapy. Furthermore, the technique could be used in defeating various diseases.

Production of Drugs and Vaccines at Lower Cost Bolstering Healthcare Segment

Based on application, the global synthetic biology market has been divided into healthcare, chemicals, agriculture, and others. The healthcare segment accounted for the largest share of the global synthetic biology market in 2021. This can be ascribed to the increase in utilization of synthetic biology technique to produce drugs and vaccines at lower cost. furthermore, the commercial availability of synthetic DNA and synthetic genes is driving the healthcare segment.

Regional Analysis of Global Synthetic Biology Market

According to the synthetic biology market research analysis, Europe accounted for major share of the global synthetic biology market in 2021. This can be ascribed to consistent efforts by the European Union (EU) toward the development of synthetic biology in the region. Increase in application of synthetic biology techniques in the field of energy, health, environment, and other areas is driving the market in Europe. The European Commission has provided funding for an initiative on New and Emerging Technologies (NEST) within the 6th Framework Programme (FP6). This initial funding was intended to encourage synthetic biology research in Europe that later would be supported by local funding agencies. Additional investment came as part of the Horizon 2020 Programme, which ran from 2014 to 2020, offering a total of 21 grants focused on synthetic biology. Thus, rigorous efforts of these organizations is likely to provide a strong platform for the development of synthetic biology in Europe.

North America held the second-largest share of the global market in 2021. Increase in scientific research and novel technologies that could expand the scope for the development of synthetic biology is propelling the market in the region. Synthetic biology is rapidly growing in scientific and innovative sectors owing to its potential impact on health, environment, security, and human rights.

Analysis of Key Players in Global Synthetic Biology Market

The global synthetic biology market is consolidated, with presence of a small number of large companies. Majority of the companies are investing significantly in research and development activities, primarily to introduce environmentally-friendly products. Expansion of product portfolio and mergers & acquisitions are key strategies adopted by major players. Leading players in the global synthetic biology market are Bristol-Myers Squibb, Gevo, Inc., Life Technologies, DSM, DuPont, Inc., Genomatica, Inc., LS9, Inc., Amyris, Inc., Codexis, Inc., Twist Bioscience, Ginkgo Bioworks, GenScript, Insitro, ElevateBio, and Precigen, Inc.

Key Developments in Global Synthetic Biology Market

  • On September 6, 2022, Synlogic, Inc. collaborated with Roche for the development of novel synthetic biotic to treat inflammatory bowel disease
  • In August 2022, A-Alpha Bio announced a collaboration with Bristol-Myers Squibb to discover molecular glue targets for protein degradation
  • On April 5, 2022, Twist Bioscience Corporation announced a new supply agreement with Ginkgo Bioworks for expanding the depth and breadth of the collaboration in the synthetic biology ecosystem
  • In August 2021, Codex DNA, one of the pioneers of the automated benchtop synthetic biology systems, announced a collaboration with researchers from the U.S. Department of Agriculture’s Research Service to identify the scalable therapeutic measures against citrus greening disease

Each of these players has been profiled in the synthetic biology market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

Global Synthetic Biology Market Snapshot

Attribute

Detail

Market Size Value in 2021

US$ 10.7 Bn

Market Forecast Value in 2031

More than US$ 74.7 Bn

Growth Rate

(CAGR)

21.3%

Forecast Period

2022–2031

Historical Data Available for

2017–2020

Quantitative Units

US$ Bn for Value

Market Analysis

It includes segment analysis at global as well as regional level. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis.

Competition Landscape

  • Market share analysis by company (2021)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Market Segmentation

  • Product Type
    • Core Products
      • Synthetic DNA
      • Synthetic Genes
      • Synthetic Cells
      • XNA & Chassis Organisms
      • Others
    • Enabling Products
      • DNA Synthesis
      • Oligonucleotide Synthesis
  • Technology
    • Genome Engineering
    • DNA Sequencing
    • Bioinformatics
    • Biological Components & Integrated Systems
    • Nanotechnology
    • Others
  • Application
    • Healthcare
    • Chemicals
    • Agriculture
    • Others

Regions Covered

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Russia & CIS
  • Japan
  • China
  • India
  • ASEAN
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa

Companies Profiled

  • Bristol-Myers Squibb
  • Gevo, Inc.
  • Life Technologies
  • DSM
  • DuPont, Inc.
  • Genomatica, Inc.
  • LS9 Inc.
  • Amyris, Inc.
  • Codexis, Inc.
  • Twist Bioscience
  • Ginkgo Bioworks
  • GenScript
  • Insitro
  • ElevateBio
  • Precigen, Inc.

Customization Scope

Available upon request

Pricing

Available upon request

Synthetic Biology Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Frequently Asked Questions

How big was the global synthetic biology market in 2021?

The global synthetic biology market was valued at US$ 10.7 Bn in 2021

How big will be the global synthetic biology market in 2031?

The global synthetic biology market is projected to reach more than US$ 74.7 Bn by 2031

What was the CAGR of the global synthetic biology market from 2017 to 2021?

The global synthetic biology market advanced at a CAGR of 21.7% from 2017 to 2021

What will be the CAGR of the global synthetic biology market during the forecast period (2022–2031)?

The global synthetic biology market is anticipated to advance at a CAGR of 21.3% from 2022 to 2031

What are the prominent trends that affect market growth?

Rise in demand for improved drugs & vaccines and advancement in molecular biology

Which region is likely to account for the major market share during the forecast period?

Europe is expected to account for the largest share of the global market during the forecast period

Who are the prominent players in the global synthetic biology market?

Bristol-Myers Squibb, Gevo, Inc., Life Technologies, DSM, DuPont, Inc., Genomatica, Inc., LS9, Inc., Amyris, Inc., Codexis, Inc., Twist Bioscience, Ginkgo Bioworks, GenScript, Insitro, ElevateBio, and Precigen, Inc.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Synthetic Biology Market

4. Market Overview

    4.1. Introduction

        4.1.1. Segment Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Synthetic Biology Market Analysis and Forecast, 2017–2031

        4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

    5.1. Key industry events (mergers & acquisitions, product launch, partnerships, etc.)

    5.2. Technological advancements

    5.3. Government funding & funding deals

    5.4. Covid-19 Pandemic impact on the Industry

6. Global Synthetic Biology Market Analysis and Forecast, by Product

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by Product, 2017–2031

        6.3.1. Core Products

            6.3.1.1. Synthetic DNA

            6.3.1.2. Synthetic Genes

            6.3.1.3. Synthetic Clones

            6.3.1.4. Synthetic Cells

            6.3.1.5. XNA & Chassis Organisms

            6.3.1.6. Others

        6.3.2. Enabling Products

            6.3.2.1. DNA Synthesis

            6.3.2.2. Oligonucleotide Synthesis

    6.4. Market Attractiveness Analysis, by Product

7. Global Synthetic Biology Market Analysis and Forecast, by Technology

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast, by Application, 2017–2031

        7.3.1. Genome Engineering

        7.3.2. DNA Sequencing

        7.3.3. Bioinformatics

        7.3.4. Biological Components & Integrated Systems

        7.3.5. Nanotechnology

        7.3.6. Others

    7.4. Market Attractiveness Analysis, by Technology

8. Global Synthetic Biology Market Analysis and Forecast, by Application

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Market Value Forecast, by Application, 2017–2031

        8.3.1. Healthcare

        8.3.2. Chemicals

        8.3.3. Agriculture

        8.3.4. Others

    8.4. Market Attractiveness Analysis, by Application

9. Global Synthetic Biology Market Analysis and Forecast, by Region

    9.1. Key Findings

    9.2. Market Value Forecast, by Region

        9.2.1. North America

        9.2.2. Europe

        9.2.3. Asia Pacific

        9.2.4. Latin America

        9.2.5. Middle East & Africa

    9.3. Market Attractiveness Analysis, by Region

10. North America Synthetic Biology Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value Forecast, by Product, 2017–2031

        10.2.1. Core Products

            10.2.1.1. Synthetic DNA

            10.2.1.2. Synthetic Genes

            10.2.1.3. Synthetic Clones

            10.2.1.4. Synthetic Cells

            10.2.1.5. XNA & Chassis Organisms

            10.2.1.6. Others

        10.2.2. Enabling Products

            10.2.2.1. DNA Synthesis

            10.2.2.2. Oligonucleotide Synthesis

    10.3. Market Value Forecast, by Technology, 2017–2031

        10.3.1. Genome Engineering

        10.3.2. DNA Sequencing

        10.3.3. Bioinformatics

        10.3.4. Biological Components & Integrated Systems

        10.3.5. Nanotechnology

        10.3.6. Others

    10.4. Market Value Forecast, by Application, 2017–2031

        10.4.1. Healthcare

        10.4.2. Chemicals

        10.4.3. Agriculture

        10.4.4. Others

    10.5. Market Value Forecast, by Country, 2017–2031

        10.5.1. U.S.

        10.5.2. Canada

    10.6. Market Attractiveness Analysis

        10.6.1. By Product

        10.6.2. By Technology

        10.6.3. By Application

        10.6.4. By Country

11. Europe Synthetic Biology Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Product, 2017–2031

        11.2.1. Core Products

            11.2.1.1. Synthetic DNA

            11.2.1.2. Synthetic Genes

            11.2.1.3. Synthetic Clones

            11.2.1.4. Synthetic Cells

            11.2.1.5. XNA & Chassis Organisms

            11.2.1.6. Others

        11.2.2. Enabling Products

            11.2.2.1. DNA Synthesis

            11.2.2.2. Oligonucleotide Synthesis

    11.3. Market Value Forecast, by Technology, 2017–2031

        11.3.1. Genome Engineering

        11.3.2. DNA Synthesis

        11.3.3. Bioinformatics

        11.3.4. Biological Components & Integrated Systems

        11.3.5. Nanotechnology

        11.3.6. Others

    11.4. Market Value Forecast, by Application, 2017–2031

        11.4.1. Healthcare

        11.4.2. Chemicals

        11.4.3. Agriculture

        11.4.4. Others

    11.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        11.5.1. Germany

        11.5.2. U.K.

        11.5.3. France

        11.5.4. Italy

        11.5.5. Spain

        11.5.6. Rest of Europe

    11.6. Market Attractiveness Analysis

        11.6.1. By Product

        11.6.2. By Technology

        11.6.3. By Application

        11.6.4. By Country/Sub-region

12. Asia Pacific Synthetic Biology Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Product, 2017–2031

        12.2.1. Core Products

            12.2.1.1. Synthetic DNA

            12.2.1.2. Synthetic Genes

            12.2.1.3. Synthetic Clones

            12.2.1.4. Synthetic Cells

            12.2.1.5. XNA & Chassis Organisms

            12.2.1.6. Others

        12.2.2. Enabling Products

            12.2.2.1. DNA Synthesis

            12.2.2.2. Oligonucleotide Synthesis

    12.3. Market Value Forecast, by Technology, 2017–2031

        12.3.1. Genome Engineering

        12.3.2. DNA Sequencing

        12.3.3. Bioinformatics

        12.3.4. Biological Components & Integrated Systems

        12.3.5. Nanotechnology

        12.3.6. Others

    12.4. Market Value Forecast, by Application, 2017–2031

        12.4.1. Healthcare

        12.4.2. Chemicals

        12.4.3. Agriculture

        12.4.4. Others

    12.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        12.5.1. China

        12.5.2. Japan

        12.5.3. India

        12.5.4. Australia & New Zealand

        12.5.5. Rest of Asia Pacific

    12.6. Market Attractiveness Analysis

        12.6.1. By Product

        12.6.2. By Technology

        12.6.3. By Application

        12.6.4. By Country/Sub-region

13. Latin America Synthetic Biology Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast, by Product, 2017–2031

        13.2.1. Core Products

            13.2.1.1. Synthetic DNA

            13.2.1.2. Synthetic Genes

            13.2.1.3. Synthetic Clones

            13.2.1.4. Synthetic Cells

            13.2.1.5. XNA & Chassis Organisms

            13.2.1.6. Others

        13.2.2. Enabling Products

            13.2.2.1. DNA Synthesis

            13.2.2.2. Oligonucleotide Synthesis

    13.3. Market Value Forecast, by Technology, 2017–2031

        13.3.1. Genome Engineering

        13.3.2. DNA Sequencing

        13.3.3. Bioinformatics

        13.3.4. Biological Components & Integrated Systems

        13.3.5. Nanotechnology

        13.3.6. Others

    13.4. Market Value Forecast, by Application, 2017–2031

        13.4.1. Healthcare

        13.4.2. Chemicals

        13.4.3. Agriculture

        13.4.4. Others

    13.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        13.5.1. Brazil

        13.5.2. Mexico

        13.5.3. Rest of Latin America

    13.6. Market Attractiveness Analysis

        13.6.1. By Product

        13.6.2. By Technology

        13.6.3. By Application

        13.6.4. By Country/Sub-region

14. Middle East & Africa Synthetic Biology Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Market Value Forecast, by Product, 2017–2031

        14.2.1. Core Products

            14.2.1.1. Synthetic DNA

            14.2.1.2. Synthetic Genes

            14.2.1.3. Synthetic Clones

            14.2.1.4. Synthetic Cells

            14.2.1.5. XNA & Chassis Organisms

            14.2.1.6. Others

        14.2.2. Enabling Products

            14.2.2.1. DNA Synthesis

            14.2.2.2. Oligonucleotide Synthesis

    14.3. Market Value Forecast, by Technology, 2017–2031

        14.3.1. Genome Engineering

        14.3.2. DNA Synthesis

        14.3.3. Bioinformatics

        14.3.4. Biological Components & Integrated Systems

        14.3.5. Nanotechnology

        14.3.6. Others

    14.4. Market Value Forecast, by Application, 2017–2031

        14.4.1. Healthcare

        14.4.2. Chemicals

        14.4.3. Agriculture

        14.4.4. Others

    14.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        14.5.1. GCC Countries

        14.5.2. South Africa

        14.5.3. Rest of Middle East & Africa

    14.6. Market Attractiveness Analysis

        14.6.1. By Product

        14.6.2. By Technology

        14.6.3. By Application

        14.6.4. By Country/Sub-region

15. Competition Landscape

    15.1. Market Player – Competition Matrix (by tier and size of companies)

    15.2. Market Share/Ranking Analysis, by Company, 2021

    15.3. Company Profiles

        15.3.1. Bristol-Myers Squibb

            15.3.1.1. Company Overview

            15.3.1.2. Product Portfolio

            15.3.1.3. SWOT Analysis

            15.3.1.4. Strategic Overview

        15.3.2. Gevo, Inc.

            15.3.2.1. Company Overview

            15.3.2.2. Product Portfolio

            15.3.2.3. SWOT Analysis

            15.3.2.4. Strategic Overview

        15.3.3. Life Technologies

            15.3.3.1. Company Overview

            15.3.3.2. Product Portfolio

            15.3.3.3. SWOT Analysis

            15.3.3.4. Strategic Overview

        15.3.4. DSM

            15.3.4.1. Company Overview

            15.3.4.2. Product Portfolio

            15.3.4.3. SWOT Analysis

            15.3.4.4. Strategic Overview

        15.3.5. DuPont, Inc.

            15.3.5.1. Company Overview

            15.3.5.2. Product Portfolio

            15.3.5.3. SWOT Analysis

            15.3.5.4. Strategic Overview

        15.3.6. Genomatica, Inc.

            15.3.6.1. Company Overview

            15.3.6.2. Product Portfolio

            15.3.6.3. SWOT Analysis

            15.3.6.4. Strategic Overview

        15.3.7. LS9, Inc.

            15.3.7.1. Company Overview

            15.3.7.2. Product Portfolio

            15.3.7.3. SWOT Analysis

            15.3.7.4. Strategic Overview

        15.3.8. Amyris, Inc.

            15.3.8.1. Company Overview

            15.3.8.2. Product Portfolio

            15.3.8.3. SWOT Analysis

            15.3.8.4. Strategic Overview

        15.3.9. Codexis, Inc.

            15.3.9.1. Company Overview

            15.3.9.2. Product Portfolio

            15.3.9.3. SWOT Analysis

            15.3.9.4. Strategic Overview

        15.3.10. Twist Bioscience

            15.3.10.1. Company Overview

            15.3.10.2. Product Portfolio

            15.3.10.3. SWOT Analysis

            15.3.10.4. Strategic Overview

        15.3.11. Ginkgo Bioworks

            15.3.11.1. Company Overview

            15.3.11.2. Product Portfolio

            15.3.11.3. SWOT Analysis

            15.3.11.4. Strategic Overview

        15.3.12. GenScript

            15.3.12.1. Company Overview

            15.3.12.2. Product Portfolio

            15.3.12.3. SWOT Analysis

            15.3.12.4. Strategic Overview

        15.3.13. Insitro

            15.3.13.1. Company Overview

            15.3.13.2. Product Portfolio

            15.3.13.3. SWOT Analysis

            15.3.13.4. Strategic Overview

        15.3.14. ElevateBio

            15.3.14.1. Company Overview

            15.3.14.2. Product Portfolio

            15.3.14.3. SWOT Analysis

            15.3.14.4. Strategic Overview

        15.3.15. Precigen, Inc.

            15.3.15.1. Company Overview

            15.3.15.2. Product Portfolio

            15.3.15.3. SWOT Analysis

            15.3.15.4. Strategic Overview

List of Tables

Table 01: Global Synthetic Biology Market Value (US$ Mn) Forecast, by Product, 2017‒2031

Table 02: Synthetic Biology Market Value (US$ Mn) Forecast, by 2017‒2031, by Technology

Table 03: Global Synthetic Biology Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 04: Global Synthetic Biology Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 05: North America Synthetic Biology Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 06: North America Synthetic Biology Market Value (US$ Mn) Forecast, by Product, 2017‒2031

Table 07: North America Synthetic Biology Market Value (US$ Mn) Forecast, by Technology, 2017‒2031

Table 08: North America Synthetic Biology Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 09: Europe Synthetic Biology Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031

Table 10: Europe Synthetic Biology Market Value (US$ Mn) Forecast, by Product, 2017‒2031

Table 11: Europe Synthetic Biology Market Value (US$ Mn) Forecast, by Technology, 2017‒2031

Table 12: Europe Synthetic Biology Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 13: Asia Pacific Synthetic Biology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 14: Asia Pacific Synthetic Biology Market Value (US$ Mn) Forecast, by Product, 2017‒2031

Table 15: Asia Pacific Synthetic Biology Market Value (US$ Mn) Forecast, by Technology, 2017‒2031

Table 16: Asia Pacific Synthetic Biology Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 17: Latin America Synthetic Biology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

Table 18: Latin America Synthetic Biology Market Value (US$ Mn) Forecast, by Product, 2017‒2031

Table 19: Latin America Synthetic Biology Market Value (US$ Mn) Forecast, by Technology, 2017‒2031

Table 20: Latin America Synthetic Biology Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 21: Middle East & Africa Synthetic Biology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

Table 22: Middle East & Africa Synthetic Biology Market Value (US$ Mn) Forecast, by Product, 2017‒2031

Table 23: Middle East & Africa Synthetic Biology Market Value (US$ Mn) Forecast, by Technology, 2017‒2031

Table 24: Middle East & Africa Synthetic Biology Market Value (US$ Mn) Forecast, by Application, 2017–2031

List of Figures

Figure 01: Global Synthetic Biology Market Value (US$ Mn) Forecast, 2017–2031

Figure 02: Global Synthetic Biology Market Value Share, by Product, 2021

Figure 03: Global Synthetic Biology Market Value Share, by Technology, 2021

Figure 04: Global Synthetic Biology Market Value Share, by Application, 2021

Figure 05: Global Synthetic Biology Market Value Share Analysis, by Product, 2021 and 2031

Figure 06: Global Synthetic Biology Market Attractiveness Analysis, by Product, 2022–2031

Figure 07: Global Synthetic Biology Market Value (US$ Mn), by Core Products, 2017‒2031

Figure 08: Global Synthetic Biology Market Value (US$ Mn), by Enabling Products, 2017‒2031

Figure 09: Global Synthetic Biology Market Value Share Analysis, by Technology, 2021 and 2031

Figure 10: Global Synthetic Biology Market Attractiveness Analysis, by Technology, 2022–2031

Figure 11: Global Synthetic Biology Market Value Share Analysis, by Application, 2021 and 2031

Figure 12: Global Synthetic Biology Market Attractiveness Analysis, by Application, 2022–2031

Figure 13: Global Synthetic Biology Market Value Share Analysis, by Region, 2021 and 2031

Figure 14: Global Synthetic Biology Market Attractiveness Analysis, by Region, 2022–2031

Figure 15: North America Synthetic Biology Market Value (US$ Mn) Forecast, 2017–2031

Figure 16: North America Synthetic Biology Market Value Share Analysis, by Country, 2021 and 2031

Figure 17: North America Synthetic Biology Market Attractiveness Analysis, by Country, 2022–2031 

Figure 18: North America Synthetic Biology Market Value Share Analysis, by Product, 2021 and 2031

Figure 19: North America Synthetic Biology Market Attractiveness Analysis, by Product, 2022–2031

Figure 20: North America Synthetic Biology Market Value Share Analysis, by Technology, 2021 and 2031

Figure 21: North America Synthetic Biology Market Attractiveness Analysis, by Technology, 2022–2031

Figure 22: North America Synthetic Biology Market Value Share Analysis, by Application, 2021 and 2031

Figure 23: North America Synthetic Biology Market Attractiveness Analysis, by Application, 2022–2031

Figure 24: Europe Synthetic Biology Market Value (US$ Mn) Forecast, 2017–2031

Figure 25: Europe Synthetic Biology Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

Figure 26: Europe Synthetic Biology Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 27: Europe Synthetic Biology Market Value Share Analysis, by Product, 2021 and 2031

Figure 28: Europe Synthetic Biology Market Attractiveness Analysis, by Product, 2022–2031

Figure 29: Europe Synthetic Biology Market Value Share Analysis, by Technology, 2021 and 2031

Figure 30: Europe Synthetic Biology Market Attractiveness Analysis, by Technology, 2022–2031

Figure 31: Europe Synthetic Biology Market Value Share Analysis, by Application, 2021 and 2031

Figure 32: Europe Synthetic Biology Market Attractiveness Analysis, by Application, 2022–2031

Figure 33: Asia Pacific Synthetic Biology Market Value (US$ Mn) Forecast, 2017–2031

Figure 34: Asia Pacific Synthetic Biology Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

Figure 35: Asia Pacific Synthetic Biology Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 36: Asia Pacific Synthetic Biology Market Value Share Analysis, by Product, 2021 and 2031

Figure 37: Asia Pacific Synthetic Biology Market Attractiveness Analysis, by Product, 2022–2031

Figure 38: Asia Pacific Synthetic Biology Market Value Share Analysis, by Technology, 2021 and 2031

Figure 39: Asia Pacific Synthetic Biology Market Attractiveness Analysis, by Technology, 2022–2031

Figure 40: Asia Pacific Synthetic Biology Market Value Share Analysis, by Application, 2021 and 2031

Figure 41: Asia Pacific Synthetic Biology Market Attractiveness Analysis, by Application, 2022–2031

Figure 42: Latin America Synthetic Biology Market Value (US$ Mn) Forecast, 2017–2031

Figure 43: Latin America Synthetic Biology Market Value Share Analysis, by Country/Sub-Region, 2021 and 2031

Figure 44: Latin America Synthetic Biology Market Attractiveness Analysis, by Country/Sub-Region, 2021-2031

Figure 45: Latin America Synthetic Biology Market Value Share Analysis, by Product, 2021 and 2031

Figure 46: Latin America Synthetic Biology Market Attractiveness Analysis, by Product, 2022–2031

Figure 47: Latin America Synthetic Biology Market Value Share Analysis, by Technology, 2021 and 2031

Figure 48: Latin America Synthetic Biology Market Attractiveness Analysis, by Technology, 2022–2031

Figure 49: Latin America Synthetic Biology Market Value Share Analysis, by Application, 2021 and 2031

Figure 50: Latin America Synthetic Biology Market Attractiveness Analysis, by Application, 2022–2031

Figure 51: Middle East & Africa Synthetic Biology Market Value (US$ Mn) Forecast, 2017–2031

Figure 52: Middle East & Africa Synthetic Biology Market Value Share Analysis, by Country/Sub-Region, 2021 and 2031

Figure 53: Middle East & Africa Synthetic Biology Market Attractiveness Analysis, by Country/Sub-Region, 2021-2031

Figure 54: Middle East & Africa Synthetic Biology Market Value Share Analysis, by Product, 2021 and 2031

Figure 55: Middle East & Africa Synthetic Biology Market Attractiveness Analysis, by Product, 2022–2031

Figure 56: Middle East & Africa Synthetic Biology Market Value Share Analysis, by Technology, 2021 and 2031

Figure 57: Middle East & Africa Synthetic Biology Market Attractiveness Analysis, by Technology, 2022–2031

Figure 58: Middle East & Africa Synthetic Biology Market Value Share Analysis, by Application, 2021 and 2031

Figure 59: Middle East & Africa Synthetic Biology Market Attractiveness Analysis, by Application, 2022–2031

Figure 60: Company Share Analysis, 2021

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

571

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved